Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …
Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …
Molecular mechanisms related to colistin resistance in Enterobacteriaceae
Z Aghapour, P Gholizadeh, K Ganbarov… - Infection and drug …, 2019 - Taylor & Francis
Colistin is an effective antibiotic for treatment of most multidrug-resistant Gram-negative
bacteria. It is used currently as a last-line drug for infections due to severe Gram-negative …
bacteria. It is used currently as a last-line drug for infections due to severe Gram-negative …
Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
R Vázquez-López, SG Solano-Gálvez… - Antibiotics, 2020 - mdpi.com
Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …
Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …
PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018 - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …
[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
Colistin, mechanisms and prevalence of resistance
AZ Bialvaei, H Samadi Kafil - Current medical research and …, 2015 - Taylor & Francis
Background: Infections caused by multi-drug-resistant Gram-negative bacteria, particularly
Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae, that …
Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae, that …
[HTML][HTML] Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside
Acinetobacter baumannii (A. baumannii) is undoubtedly one of the most successful
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …
pathogens in the modern healthcare system. With invasive procedures, antibiotic use and …
[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …